Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in AustriaArchived
This paper describes the epidemiology of rotavirus (RV) in Austrian children before and during universal mass campaign.
Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria Paulke-Korineka M, Kundib M, Rendi-Wagnerc P, de Martind A, Edere G, Schmidle-Lossa B et al. Vaccine 2011; 29: 2791–6.
This paper describes the epidemiology of rotavirus (RV) in Austrian children before and during universal mass campaign. Data from a hospital based surveillance system, representative of 30% of the country, show that incidence rates of children hospitalized with RV gastro enteritis (RV-GE) decreased in 2009 compared to 2008 and compared to the pre-vaccination period 2001–2005. Decreasing hospitalization rates from RV-GE were observed in children of all age groups, even in those not eligible for vaccination according to their age, suggesting herd immunity induced by universal mass vaccination against RV-GE. In 2009 the disease burden was highest in children below three months of age stressing the importance of the early start of the immunization course.
Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Pre-Term European Infants: A Randomized Phase IIIb StudyArchived
1 Feb 2012 - Results of this study demonstrated that the RIX4414 vaccine was well tolerated and immunogenic in pre-term European infants: more than 75% of infants had seroconverted 30-83 days after dose 2.
Impact of rotavirus vaccination on epidemiological dynamics in England and WalesArchived
9 Dec 2011 - The paper shows, through mathematical modelling, the impact of mass rotavirus vaccination in England and Wales.
Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in IrelandArchived
10 Oct 2011 - Rotavirus gastroenteritis in Ireland is a quite common and unpleasant illness, but severe disease is unusual and death extremely rare. Nonetheless, rotavirus generates considerable direct and indirect costs.